Graham Pawelec received an MA in Natural Sciences in 1978 and a PhD in Transplantation Immunology in 1982 from the University of Cambridge, UK, and the Dr. habil and Venia Legendi from the University of Tübingen, Germany, where he became Professor of Experimental Immunology in 1997. He is affiliated to the Center for Medical Research, University of Tübingen Medical School . His research interests are centered on alterations to immunity in ageing, age-associated diseases and cancer in man and the influence these have on the outcome of vaccination. He is currently focusing on mechanisms of human immunosenescence and the impact of polypathogenicity (including multiple infections, cancer, Alzheimer´s, autoimmunity) as well as stress (psychological, nutritional) on immune signatures reflecting individual immune status in the clinical context. He is a Visiting Professor, Nottingham Trent University, UK, and Honorary Professor at Manchester University, UK. He is Co-Editor-in Chief of Cancer Immunology Immunotherapy. Deputy Editor of Immunity & Ageing and the Journal of Translational Medicine, Associate Editor of Mechanisms of Ageing & Development, and on the Board of Experimental Gerontology, Age, Biogerontology and the Journals of Gerontology. He has coordinated three European Union collaborative programs on immunosenescence (EUCAMBIS, ImAginE and T-CIA) and two on cancer vaccine research (EUCAPS, ESTDAB).